T1	Treatment 0 10	Dopexamine
T2	Treatment 69 132	goal-directed fluid therapy undergoing major abdominal surgery.
T3	Treatment 145 155	Dopexamine
T4	Treatment 375 385	dopexamine
T5	Treatment 409 432	major abdominal surgery
T6	Treatment 538 557	low-dose dopexamine
T7	Treatment 715 749	undergoing major abdominal surgery
T8	Treatment 857 879	of low-dose dopexamine
T9	Treatment 893 922	after major abdominal surgery
T10	Treatment 1026 1064	major colorectal or urological surgery
T11	Treatment 1387 1460	bolus of Voluven (6% hydroxyethyl starch 130/0.4 in 0.9% sodium chloride)
T12	Treatment 1527 1544	either dopexamine
T13	Treatment 1567 1575	min(-1))
T14	Treatment 1605 1611	During
T15	Treatment 1627 1637	boluses of
T16	Treatment 1774 1794	regime with Hartmann
T17	Treatment 2132 2154	was 55% in the control
T18	Treatment 2161 2178	versus 47% in the
T19	Treatment 2394 2411	administration of
T20	Treatment 2509 2545	effective use of goal-directed fluid
T21	Treatment 2589 2603	routine use of
